Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=6
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=6
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=6
PubPharm (3.278)
51
GEN1042 safety trial in patients with malignant solid tumors : A first-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1042 in subjects with malignant solid tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
52
Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients with Alexander Disease : A Phase 1-3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients with Alexander Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
53
Phase 1b/2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia : Phase 1b/2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
54
A study of BLU-667 in patients with lung cancer, and thyroid cancer, and other solid tumors : A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - ARROW
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
55
Study of tazemetostat or placebo in combination with lenalidomide plus rituximab in subjects with relapsed/refractory follicular lymphoma : SYMPHONY-1: A Phase 1b/3 double-blind, randomized, active-controlled, 3-stage, biomarker adaptive study of tazemetostat or placebo in combination with lenalidomide plus rituximab in subjects with relapsed/refractory follicular lymphoma - SYMPHONY-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
56
Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases : Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcutaneous human immunoglobulin (Newnorm) in patients with primary immunodeficiency diseases
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
57
An Open-Label, Multicenter Study of the Safety and Efficacy in Subjects with Relapsed/Refractory Myelofibrosis and in Janus-associated Kinase Inhibitor-Intolerant Myelofibrosis : An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 with TL-895 in Subjects with Relapsed/Refractory Myelofibrosis and of KRT-232 in Janus-associated Kinase Inhibitor-Intolerant Myelofibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
58
Phase 1/2 study of GEN3014 in relapsed or refractory hematologic malignancies : An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies - Phase 1/2 trial of GEN3014 in relapsed or refractory hematologic malignancies
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
59
GEN1042 safety trial in patients with malignant solid tumors : A first-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1042 in subjects with malignant solid tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
60
Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients with Alexander Disease : A Phase 1-3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients with Alexander Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[328]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
3.278
Aufsätze
3.278
E-Artikel
3.278
E-Ressourcen
Zeitschriftentitel
3.278
WHO International Clinical Trials Registry Plat...
Thema
3.278
610
Phase: Phase 1
3.278
Recruitment Status: Authorised-recruitment may ...
3.278
Study Type: Interventional
26
Medical Condition: Advanced Solid Tumors MedDRA...
18
Medical Condition: B-cell Non-Hodgkin LymphomaD...
18
Medical Condition: High grade serous ovarian ca...
18
Medical Condition: Metastatic Castration-Resist...
18
Medical Condition: Relapsed or Refractory Multi...
14
Medical Condition: Huntington's Disease MedDRA ...
14
Medical Condition: KRAS p.G12C mutant advanced ...
14
Medical Condition: Melanoma MedDRA version: 21....
14
Medical Condition: Relapsed or Refractory Acute...
14
Medical Condition: The ‘wet’ form of age-re...
14
Medical Condition: pediatric CD22-positive rela...
12
Medical Condition: PMF or PPV- MF, or PET- MF M...
12
Medical Condition: Pediatric patients with Phil...
12
Medical Condition: Primary Myelofibrosis (PMF),...
12
Medical Condition: Relapsed/Refractory Myelofib...
12
Medical Condition: Solid Tumors MedDRA version:...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.510
2020-
768
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.240
Englisch
34
Unbestimmt
4
Italienisch
Haven't found what you're looking for?
Wird geladen...